Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome.
Razumovsky, Alexander Y, DeBusk, Karen, Calkins, Hugh et al. · Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2003
Quick Summary
When people with ME/CFS stand up quickly, they often experience dizziness and fainting. This study used ultrasound to measure blood flow in the brain during a tilt test and compared it between ME/CFS patients and healthy people. The researchers found that blood flow patterns in the brain were actually similar between the two groups, even though ME/CFS patients felt symptoms faster.
Why It Matters
Understanding why ME/CFS patients experience postural symptoms is crucial for developing targeted treatments. This study helps clarify the mechanisms behind orthostatic intolerance by showing that abnormal brain blood flow patterns may not be the primary cause, redirecting researchers to investigate other physiological mechanisms.
Observed Findings
ME/CFS patients experienced onset of orthostatic symptoms significantly faster than controls (median time P < 0.001), despite similar blood pressure changes
Middle cerebral artery blood flow velocity (CBFV) was similar between CFS and control groups at baseline and at all time points during upright tilt testing
End-tidal CO2 was significantly lower in ME/CFS patients compared to controls at test termination (P = 0.002)
Supine heart rate was elevated in ME/CFS patients at baseline, but baseline hemodynamic and CBFV measures were otherwise similar
Neurally mediated hypotension and POTS occurred at similar rates in both groups
Inferred Conclusions
Abnormal middle cerebral artery blood flow velocity changes are not the distinctive mechanism underlying postural intolerance in ME/CFS
Other factors beyond cerebral hemodynamics—possibly including respiratory or metabolic changes (reflected by lower CO2)—may be responsible for the rapid onset of orthostatic symptoms in ME/CFS
The physiological basis for faster symptom development in ME/CFS remains unexplained despite similar hemodynamic responses
Remaining Questions
What accounts for the significantly faster symptom onset in ME/CFS patients if cerebral blood flow patterns are normal?
What This Study Does Not Prove
This study does not prove that cerebral blood flow plays no role in ME/CFS symptoms—only that the pattern of blood flow changes during tilt testing does not differ significantly from controls. The lower CO2 levels in ME/CFS patients at test termination suggest other factors (such as hyperventilation or metabolic changes) may contribute to symptoms, but causation cannot be established from this observational data. The study also cannot explain why ME/CFS patients develop symptoms faster despite similar hemodynamic parameters.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What is the significance of the lower end-tidal CO2 in ME/CFS patients, and does hyperventilation or altered metabolism contribute to symptom development?
Are there regional differences in cerebral blood flow or other vascular beds (peripheral, coronary) that differ between ME/CFS and controls?
Could abnormalities in cerebral autoregulation or microvascular function exist despite normal bulk flow measurements?